Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carmelo Nucera

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Oncotarget|February 19, 2019
A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancerCarmelo Nucera
Frontiers in Endocrinology|November 9, 2013
Targeting thyroid cancer microenvironment: basic research and clinical applicationsCarmelo Nucera
Aging|August 31, 2016
Evolution of resistance to thyroid cancer therapyCarmelo Nucera
Advances in Experimental Medicine and Biology|October 19, 2021
Tumor Microenvironment-Associated Pericyte Populations May Impact Therapeutic Response in Thyroid CancerAsumi Iesato, Carmelo Nucera
Frontiers in Endocrinology|June 1, 2012
Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer?Carmelo Nucera, Alfredo Pontecorvi
Molecules (Basel, Switzerland)|June 2, 2021
Role of Regulatory Non-Coding RNAs in Aggressive Thyroid Cancer: Prospective Applications of Neural Network AnalysisAsumi Iesato, Carmelo Nucera
Endocrinology and Metabolism Clinics of North America|February 6, 2019
Coding Molecular Determinants of Thyroid Cancer Development and ProgressionVeronica Valvo, Carmelo Nucera
Current Opinion in Endocrine and Metabolic Research|December 30, 2024
Therapeutic treatments targeting communication between angiogenic and immune microenvironments in thyroid cancersAlessandro Prete, Carmelo Nucera
Aging|December 21, 2016
Effect of the micronutrient iodine in thyroid carcinoma angiogenesisKayla Daniell, Carmelo Nucera
The Journal of Clinical Endocrinology and Metabolism|October 28, 2014
Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterationsNeal Smith, Carmelo Nucera
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Oncotarget|February 19, 2019
A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancerCarmelo Nucera
Frontiers in Endocrinology|November 9, 2013
Targeting thyroid cancer microenvironment: basic research and clinical applicationsCarmelo Nucera
Aging|August 31, 2016
Evolution of resistance to thyroid cancer therapyCarmelo Nucera
Advances in Experimental Medicine and Biology|October 19, 2021
Tumor Microenvironment-Associated Pericyte Populations May Impact Therapeutic Response in Thyroid CancerAsumi Iesato, Carmelo Nucera
Frontiers in Endocrinology|June 1, 2012
Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer?Carmelo Nucera, Alfredo Pontecorvi
Molecules (Basel, Switzerland)|June 2, 2021
Role of Regulatory Non-Coding RNAs in Aggressive Thyroid Cancer: Prospective Applications of Neural Network AnalysisAsumi Iesato, Carmelo Nucera
Endocrinology and Metabolism Clinics of North America|February 6, 2019
Coding Molecular Determinants of Thyroid Cancer Development and ProgressionVeronica Valvo, Carmelo Nucera
Current Opinion in Endocrine and Metabolic Research|December 30, 2024
Therapeutic treatments targeting communication between angiogenic and immune microenvironments in thyroid cancersAlessandro Prete, Carmelo Nucera
Aging|December 21, 2016
Effect of the micronutrient iodine in thyroid carcinoma angiogenesisKayla Daniell, Carmelo Nucera
The Journal of Clinical Endocrinology and Metabolism|October 28, 2014
Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterationsNeal Smith, Carmelo Nucera
Pageof 5